The interest in sputum assessment as a non-invasive technique to retrieve c
ells and soluble material from the lung has increased and gained momentum d
uring the last decade. As a marker of inflammation in airway diseases, indu
ced sputum (IS) is a particularly promising procedure since it provides spe
cific information on both the cellular and molecular constituents in inflam
mation. From 1950-1970, sputum cells had been examined on stained smears, w
ith the procedure having been applied in both research and clinical setting
s. After having been recovered by spontaneous coughing, the cells were used
to study lung cancer and respiratory infections and, later on, to diagnose
Pneumocystis carinii pneumonia in patients infected with human immuno-defi
ciency virus (HIV). The method was widely improved upon by the induction of
Sputum with aerosol of hypertonic saline and then extended to become part
of the assessment of airway inflammation in bronchial asthma and chronic ob
structive pulmonary disease (COPD). It was recently shown that IS can be us
ed to study interstitial lung diseases (ILD) and, more specifically, pneumo
coniosis, sarcoidosis, non-granulomatous ILD and occupational lung diseases
. In light of the fact that immunologic and functional bronchopulmonary abn
ormalities may be present in up to two-thirds of patients with Crohn's dise
ase, we studied the use of IS in this condition as well. This review analyz
es the value of IS and its present applications in pulmonary medicine.